Show simple item record

dc.contributor.authorVeenis, Aaron
dc.contributor.authorHaghnegahdar, Megan
dc.contributor.authorAjlan, Radwan
dc.date.accessioned2023-06-27T16:10:49Z
dc.date.available2023-06-27T16:10:49Z
dc.date.issued2022-07-22
dc.identifier.citationVeenis, A., Haghnegahdar, M. & Ajlan, R. Mycobacterium chimaera chorioretinitis preceding central nervous system lesions: a case report and review of the literature. BMC Ophthalmol 22, 316 (2022). https://doi.org/10.1186/s12886-022-02528-2en_US
dc.identifier.urihttps://hdl.handle.net/1808/34447
dc.descriptionA grant from the One-University Open Access Fund at the University of Kansas was used to defray the author's publication fees in this Open Access journal. The Open Access Fund, administered by librarians from the KU, KU Law, and KUMC libraries, is made possible by contributions from the offices of KU Provost, KU Vice Chancellor for Research & Graduate Studies, and KUMC Vice Chancellor for Research. For more information about the Open Access Fund, please see http://library.kumc.edu/authors-fund.xml.en_US
dc.description.abstractBackground Mycobacterium chimaera ocular infection is a rare disease that is linked to bypass devices used during cardiothoracic surgeries. Reported cases in the literature of ocular involvement preceding CNS involvement are based on clinical exam with no neuroimaging. Here we present a case of M. chimaera ocular infection with no CNS M. chimaera lesions on brain magnetic resonance imaging (MRI).

Case presentation A 59-year-old female presented with altered mental status and blurred vision in February 2021. Her past medical history was significant for aortic valve replacement and ascending aortic aneurysm repair in 2017 complicated by known M. chimaera infection. She had been receiving azithromycin, ethambutol, rifampin, and amikacin as systemic anti-mycobacterium treatment. Her dilated fundus exam showed numerous yellow placoid circular lesions scattered throughout the macula and peripheral retina in both eyes with associated vitritis. Systemic workup, including brain MRI showed no acute infectious lesions. Her infections workup was unremarkable except for a positive toxoplasma IgM, for which she was treated with sulfamethoxazole/trimethoprim. One month later, a head computed tomography showed new numerous scattered round foci of hyperdensity throughout the cerebrum and brainstem thought to be foci of M. chimaera infection. Clofazimine was added per culture and sensitivity. MRI brain 1 month later showed mild decrease in conspicuity and number of these intensities while on anti-mycobacterium treatment. Her cognition had improved at that time as well. She was seen in retina clinic 2 months later where her exam showed similar retinal lesions with no associated vitritis or anterior chamber cell in bilateral eyes, suggesting a lack of active infection. Optical coherence tomography macula showed parafoveal cystoid macular edema bilaterally. She was started on steroidal and non-steroidal anti-inflammatory eye drops.

Conclusions To the best of our knowledge, this is the first case in the literature to report M. chimaera chorioretinitis with concomitant negative neuroimaging. Chorioretinal M. chimaera lesions should motivate high suspicion of CNS involvement prompting early neurological work up.
en_US
dc.publisherBMCen_US
dc.rights© The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License.en_US
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_US
dc.subjectMycobacterium chimaeraen_US
dc.subjectChorioretinitisen_US
dc.subjectCase reporten_US
dc.titleMycobacterium chimaera chorioretinitis preceding central nervous system lesions: a case report and review of the literatureen_US
dc.typeArticleen_US
kusw.kuauthorVeenis, Aaron
kusw.kuauthorHaghnegahdar, Megan
kusw.kuauthorAjlan, Radwan
kusw.kudepartmentUniversity of Kansas School of Medicineen_US
dc.identifier.doi10.1186/s12886-022-02528-2en_US
dc.identifier.orcidhttps://orcid.org/0000-0002-5048-327Xen_US
kusw.oaversionScholarly/refereed, publisher versionen_US
kusw.oapolicyThis item meets KU Open Access policy criteria.en_US
dc.rights.accessrightsopenAccessen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

© The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License.
Except where otherwise noted, this item's license is described as: © The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License.